Patterns of β-cell autoantibody appearance and genetic associations during the first years of life

Diabetes

Volumn 62, Issue 10, 2013, Pages 3636-3640

  Ilonen, Jorma ^a,b   Hammais, Anna ^a   Laine, Antti Pekka ^a   Lempainen, Johanna ^a,c   Vaarala, Outi ^d   Veijola, Riitta ^e,f   Simell, Olli ^a,c   Knip, Mikael ^g,h,i,j  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ TAMPERE UNIVERSITY HOSPITAL   (Finland)

^j FOLKHÄLSAN RESEARCH CENTER   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GAD ANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; IA 2 ANTIBODY; INSULIN AUTOANTIBODY; PANCREAS ISLET BETA CELL AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG; INSULIN ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; MAJOR CLINICAL STUDY; MALE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22 GENE; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; DISEASE COURSE; FINLAND; FOLLOW UP; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFANT; NEWBORN; PANCREAS ISLET; DIABETES MELLITUS, TYPE 1;

AUTOANTIBODIES; AUTOIMMUNITY; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE; PROSPECTIVE STUDIES;

EID: 84891542721     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0300     Document Type: Article

References (24)

1. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010;32:468-478
2. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2012;2:a007781
3. Ziegler AG, Standl E, Albert E, Mehnert H. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes 1991;40:1146-1149
4. Sabbah E, Savola K, Ebeling T, et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000;23:1326-1332
5. Vandewalle CL, Falorni A, Lernmark A, et al. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 1997;20: 1547-1552
6. Graham J, Hagopian WA, Kockum I, et al.; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-1355
7. Wegmann DR, Eisenbarth GS. It's insulin. J Autoimmun 2000;15:286-291
8. Kupila A, Muona P, Simell T, et al.; Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a populationbased birth cohort. Diabetologia 2001;44:290-297
9. Näntö-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008;372:1746-1755
10. Siljander HT, Simell S, Hekkala A, et al. Predictive characteristics of diabetes- associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-2842
11. Hermann R, Turpeinen H, Laine AP, et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003;62:162-169
12. Kimpimäki T, Kulmala P, Savola K, et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002;87:4572-4579
13. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004; 140:882-886
14. Parikka V, Näntö-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012; 55:1926-1936
15. Ziegler AG, Bonifacio E; BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012;55:1937-1943
16. Laine AP, Holmberg H, Nilsson A, et al.; Finnish Paediatric Diabetes Registry. Two insulin gene single nucleotide polymorphisms associated with type 1 diabetes risk in the Finnish and Swedish populations. Dis Markers 2007;23:139-145
17. Walter M, Albert E, Conrad M, et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 2003;46:712-720
18. Hermann R, Laine AP, Veijola R, et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005;48:1766-1775
19. Pugliese A. Central and peripheral autoantigen presentation in immune tolerance. Immunology 2004;111:138-146
20. Mäkinen A, Härkönen T, Ilonen J, Knip M; Finnish Pediatric Diabetes Register. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur J Endocrinol 2008;159:19-26
21. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104:17040-17045
22. Achenbach P, Lampasona V, Landherr U, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009;52:1881-1888
23. Long AE, Gooneratne AT, Rokni S, Williams AJ, Bingley PJ. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort. J Clin Endocrinol Metab 2012;97:632-637
24. Yu L, Dong F, Miao D, Fouts AR, Wenzlau JM, Steck AK. Proinsulin/insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity. Diabetes Care 2013;36: 2266-2270